Xeris Biopharma Holdings Inc

Small-Cap Stocks Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks

$5.44

-0.14 (-2.51%)

As of Mar 22, 10:09 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +757.5% upside

Low Target $35.62

Average Target $46.65

High Target $60.75

Current Price $5.44

Current
$5.44

Target
$46.65

$35.62 $46.65 avg $60.75

Scenario Analysis

Bear Case

$35.62

554.8%

Low target

Base Case

$46.65

+757.5%

Avg target

Bull Case

$60.75

+1,016.7%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$10.08

-46.0% from high

52-Week Low

$3.81

+43.0% from low

Target vs 52W High

$46.65

+362.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%